• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

2015 West Nile Virus Update in the United States

September 25, 2015

Side View Mosquito Portrait

The West Nile Virus (WNV) is an arbovirus that was first identified in the United States in 1999 and is endemic in much of the world. Although there is no specific treatment for infection or vaccine for prevention, most cases of WNV are asymptomatic and resolve on their own. One in five WNV-infected persons will develop a fever with other symptoms, but 1% of infections can cause permanent and sometimes fatal neurological damage. As of September 22, 2015, 877 cases of WNV infections in humans have been reported to the CDC from 45 states and the District of Columbia. In addition to exposure by infected mosquitos, WNV can be transmitted by transfusions, organ transplantations, and mother-to-child transmission. To reduce the risk of transfusion-transmitted infections, blood collection agencies have been screening all donations for WNV since 2003.  Infected individuals should not donate blood for 120 days.

 

Reference

Centers for Disease Control and Prevention:  West Nile Virus.  September 22, 2015.  Accessed online September 20, 2015.  http://www.cdc.gov/westnile/index.html

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Evidence-Based Transfusion Guidelines Needed for Thalassemia Population

  • U.S. 2011 National Blood Collection and Utilization Survey Report

  • Global Variations in Blood Safety and Availability Based on WHO Report

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley